Your session is about to expire
← Back to Search
Pre-Chemoradiation Hypofractionated Radiation for Lung Cancer
Study Summary
This trial is testing whether targeted radiation to the primary tumor before standard chemo and radiation therapy can help treat patients with stage II or III non-small cell lung cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had a lung removed.I have no other cancers except for certain skin, bladder, or cervical cancers, or any cancer I had is in remission for 3+ years.I had a chest surgery over 3 weeks ago and have healed well.I have had radiation therapy before in the same area.I've had recent health checks including blood tests and, if applicable, a pregnancy test.Your total bilirubin level is not more than 1.5 times the upper limit of normal.Your hemoglobin level is at least 9 grams per deciliter.Your platelet count is at least 100 billion per liter.Your AST and ALT levels should be less than or equal to 2.5 times the upper limit of normal.I have cancer nodules in the same or nearby lung lobe, not exceeding 6 cm.I have a history of scleroderma or idiopathic pulmonary fibrosis.I have small fluid build-ups not visible on an X-ray and too minor to drain.My lung cancer is confirmed to be non-small cell type.My condition cannot be treated with surgery.My primary tumor is 6 cm or smaller.My tests show no cancer cells in the fluid from my chest.My organs are functioning well, as confirmed by tests within the last 30 days.Women who could become pregnant must have a negative pregnancy test within 14 days of joining the study. A urine test for human gonadotropin (HCG) can be used to check for pregnancy.I do not have severe uncontrolled nerve pain or damage.You cannot have an MRI scan if you have a pacemaker, metal implants, aneurysm clips, allergy to contrast dye, are pregnant, nursing, or weigh more than 350 pounds.I am fully active or restricted in physically strenuous activity but can do light work.I have cancerous nodules in the opposite lobe of my lung.All my side effects from previous treatments are mild, except for hair loss.My cancer has spread to other parts of my body.I've had specific scans within the last 2 months for my condition.My cancer has spread to the lymph nodes on the opposite side of my chest.My lung cancer is at an early to mid-stage but hasn't spread to distant organs.I haven't had chemotherapy or targeted cancer drugs in over 2 years.My lung cancer can be measured and is not undetectable.Your white blood cell count is at least 1.5 billion per liter.I am using or willing to use birth control or practice abstinence during the study.My kidney function, measured by creatinine levels, is within the normal range.
- Group 1: Treatment (hypofractionated radiation boost, chemoradiation)
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the FDA sanction hypofractionated radiation therapy?
"Our experts graded hypofractionated radiation therapy's safety at a score of 2 based on the Phase 2 trial data, which contains some evidence of its security but nothing to validate its efficacy."
How many subjects are participating in this experiment?
"Unfortunately, this study is not currently enrolling individuals. It was initially posted on December 8th 2014 and last modified on November 24th 2020. If you are seeking alternative clinical trials, there are 1,908 studies actively searching for patients with non-small cell lung carcinoma as well as 901 trials looking to recruit participants that could benefit from hypofractionated radiation therapy."
What maladies are most commonly managed with hypofractionated radiation therapy?
"Advance directives are typically addressed with hypofractionated radiation therapy, which is also useful for treating Merkel cell cancer, neoplasm metastasis and prostate cancer."
Is recruitment for this trial still available?
"This research project is no longer in the process of recruiting participants, as it was last updated on November 24th 2020. If you are looking for additional studies to join, there are 1908 medical trials that involve non-small cell lung carcinoma and 901 clinical investigations into hypofractionated radiation therapy actively enrolling patients currently."
Could you provide insight into other experiments that have explored hypofractionated radiation therapy?
"Presently, a total of 901 clinical trials involving hypofractionated radiation therapy are in progress, with 325 studies at the Phase 3 stage. A bulk of these research projects are located within New york City but there is also an abundance of sites scattered across 50938 locations to conduct this investigation."
Share this study with friends
Copy Link
Messenger